WHO ICTRP trial
Pharmacokinetics of ertapenem in patients with severe sepsis and intraabdominal…
EUCTR2009-015948-42-EE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2009-015948-42-EE |
|---|---|
| Public title | Pharmacokinetics of ertapenem in patients with severe sepsis and intraabdominal infection |
| Scientific title | Pharmacokinetics of ertapenem in patients with severe sepsis and intraabdominal infection |
| Primary sponsor | University of Tartu, Faculty of Medicine |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Estonia |
| Conditions | Severe sepsis caused by intraabdominal infection either peritonitis or pancreatitis |
| Interventions | Trade Name: Invanz Pharmaceutical Form: Powder for concentrate for solution for infusion INN or Proposed INN: ERTAPENEM CAS Number: 153832-46-3 Current Sponsor code: 179 Other descriptive name: Invanz Concentration unit: g gram(s)… |
| Registration date | Jul 10, 2009 |
| Target size | 8 |
| Secondary IDs | 179 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: